ATLAAS (Atraumatic Left Atrial Appendage System) (AD)
K-Number: K252917 · 2026-05-22
Device Summary
Frequently Asked Questions
What is the ATLAAS (Atraumatic Left Atrial Appendage System) (AD)?
ATLAAS (Atraumatic Left Atrial Appendage System) (AD) is a medical device that received FDA 510(k) clearance on 2026-05-22. The listed applicant is Genesee Biomedical, Inc.. The 510(k) number is K252917.
When did ATLAAS (Atraumatic Left Atrial Appendage System) (AD) receive FDA 510(k) clearance?
ATLAAS (Atraumatic Left Atrial Appendage System) (AD) received FDA 510(k) clearance on 2026-05-22, under 510(k) number K252917.
Who is the listed applicant for ATLAAS (Atraumatic Left Atrial Appendage System) (AD)?
The FDA 510(k) record lists Genesee Biomedical, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for ATLAAS (Atraumatic Left Atrial Appendage System) (AD)?
The FDA product code for ATLAAS (Atraumatic Left Atrial Appendage System) (AD) is PZX.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Genesee Biomedical, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: PZX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.